NPM1-mutated AML prognosis was refined using a new genetic model integrating co-mutations, improving risk classification and ...
Accurate risk assessment is a highly technical process for patients with acute myeloid leukemia (AML). A new tool could help make such assessments available even when patients can’t get to a specialty ...
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. AI, and especially agentic AI tools, are evolving at a rapid speed, with the use of AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results